Copernicus Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-6,000
| Closed | -$649K | – | 12 |
|
2021
Q1 | $649K | Buy |
6,000
+1,324
| +28% | +$143K | 10.49% | 4 |
|
2020
Q4 | $501K | Sell |
4,676
-143,763
| -97% | -$15.4M | 7.81% | 4 |
|
2020
Q3 | $13M | Buy |
148,439
+38,439
| +35% | +$3.37M | 12.38% | 1 |
|
2020
Q2 | $10.8M | Buy |
+110,000
| New | +$10.8M | 11.84% | 1 |
|
2020
Q1 | – | Sell |
-76,957
| Closed | -$6.81M | – | 15 |
|
2019
Q4 | $6.81M | Sell |
76,957
-55,043
| -42% | -$4.87M | 8.93% | 5 |
|
2019
Q3 | $10M | Buy |
+132,000
| New | +$10M | 9.3% | 4 |
|